Point72 Middle East Fze Merck & Co., Inc. Transaction History

Point72 Middle East Fze

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$100.18 - $109.02 $22.4 Million - $24.3 Million	-223,351 Reduced 88.39%	29,323 $3.2 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $26 Million - $28.9 Million	252,674 New	252,674 $26 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $13 Million - $14.5 Million	-125,899 Reduced 99.55%	573 $60,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $11.1 Million - $14.2 Million	126,472 New	126,472 $0

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.